FibroBiologics, Inc.
FBLG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001958777
No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding FibroBiologics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 55 | 46 | −9 |
| Shares | 5.39M | 4.42M | −975.7K (−18.1%) |
| Value | $2.93M | $993.8K | −$1.94M (−66.1%) |
New holders (6)
Institutions that held FibroBiologics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 149,763 | $33.7K | 0.00% |
| AMG National Trust Bank | 138,960 | $31.3K | 0.00% |
| XTX Topco Ltd | 37,919 | $8.53K | 0.00% |
| DRW Securities, LLC | 33,348 | $7.50K | 0.00% |
| Point72 Asset Management, L.P. | 14,476 | $3.26K | 0.00% |
| Disciplined Equity Management, Inc. | 1,000 | $418 | 0.00% |
Sold out (15)
Institutions that held FibroBiologics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Yorkville Advisors Global, LP | 509,787 | $278.4K |
| Landscape Capital Management, L.L.C. | 350,000 | $191.2K |
| GTS Securities LLC | 308,661 | $168.5K |
| Citadel Advisors LLC | 211,139 | $115.3K |
| HRT Financial LP | 44,145 | $24.0K |
| LPL Financial LLC | 17,570 | $9.60K |
| Runnymede Capital Advisors, Inc. | 10,000 | $5.46K |
| FMR LLC | 1,200 | $655 |
| EverSource Wealth Advisors, LLC | 52 | $28 |
| Morgan Stanley | 13 | $7 |
| True Wealth Design, LLC | 10 | $6 |
| SRS Capital Advisors, Inc. | 2 | $1 |
| IFP Advisors, Inc | 2 | $1 |
| CWM, LLC | 259 | $0 |
| Luminus Management LLC | 26,629 | – |